Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer
Abstract Background Expression of the dimeric M2 isoenzyme of pyruvate kinase, termed Tumor M2-PK, is increased in some human cancers. This study evaluates the potential role of pre-operative Tumor M2-PK as a marker of prognosis in patients with pancreatic malignancy. Methods Seventy-three consecuti...
Main Authors: | Indika A. Bandara, Minas Baltatzis, Sudip Sanyal, Ajith K. Siriwardena |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-018-1360-3 |
Similar Items
-
Expression of tumor pyruvate kinase M2 isoform in plasma and stool of patients with colorectal cancer or adenomatous polyps
by: Farideh Rigi, et al.
Published: (2020-07-01) -
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells
by: Nina Klieber, et al.
Published: (2024-02-01) -
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer
by: Goran Hamid Mohammad, et al.
Published: (2019-09-01) -
Epidermal Growth Factor Receptor in Pancreatic Cancer
by: Ajith K. Siriwardena, et al.
Published: (2011-03-01) -
Pancreatic Tumors in Children
by: Hasan Özkan GEZER, et al.
Published: (2021-03-01)